SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-013245
Filing Date
2021-10-18
Accepted
2021-10-18 07:02:18
Documents
14
Period of Report
2021-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20211014x8k.htm   iXBRL 8-K 40567
2 EX-99.1 omer-20211014xex99d1.htm EX-99.1 10902
3 GRAPHIC omer-20211014xex99d1001.jpg GRAPHIC 3542
  Complete submission text file 0001558370-21-013245.txt   180441

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20211014.xsd EX-101.SCH 3205
5 EX-101.LAB omer-20211014_lab.xml EX-101.LAB 15501
6 EX-101.PRE omer-20211014_pre.xml EX-101.PRE 10532
7 EXTRACTED XBRL INSTANCE DOCUMENT omer-20211014x8k_htm.xml XML 4670
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 211327306
SIC: 2834 Pharmaceutical Preparations